FMP
AXSM icon

Financial Management Professionals’s Axsome Therapeutics AXSM Stock Holding History

Financial Management Professionals’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$4K – 925
2022
Q2 		$4K Hold
100
– – ﹤0.01% 637
2022
Q1 		$4K Buy
+100
New +$3.1K ﹤0.01% 654

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Financial Management Professionals's AXSM Position: Q3 2022 in Review

Financial Management Professionals sold out of Axsome Therapeutics (AXSM) in Q3 2022, closing a stake of 100 shares — an estimated $4K sold.

Financial Management Professionals first reported a position in AXSM in Q1 2022 and held it in 2 quarters. The position peaked at $4K in Q2 2022. 187 funds tracked by Wall St. Rank hold AXSM as of Q3 2022.

  • Financial Management Professionals reported no remaining Axsome Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Financial Management Professionals sold 100 Axsome Therapeutics shares in Q3 2022, an estimated $4K.
  • Financial Management Professionals first reported a position in Axsome Therapeutics in Q1 2022 and held it in 2 quarters.
  • Financial Management Professionals's Axsome Therapeutics position peaked at $4K in Q2 2022.
  • 187 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2022.

Based on Financial Management Professionals's 13F filing for Q3 2022, filed 27 Oct 2022.